Antimicrobial Lipids of the Skin and Oral Mucosa

Innate Immune System of Skin and Oral Mucosa: Properties and Impact in Pharmaceutics, Cosmetics, and Personal Care Products

Volumn , Issue , 2011, Pages 75-81

  Brogden, Kim A ^a   Drake, David R ^a   Dawson, Deborah V ^a   Hill, Jennifer R ^a   Bratt, Carol L ^a   Wertz, Philip W ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Antimicrobial lipids and peptides antimicrobial lipids of skin and oral mucosa; Lauric acid and sapienic acid lauric acid, against Gram positive bacteria; Sphingosine gradient, ceramidase action cell proliferation, differentiation regulation

Indexed keywords

EID: 84877810705     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118025338.ch4     Document Type: Chapter

References (39)

1. Rothman S, Lorincz AL. Defense mechanisms of the skin. Ann. Rev. Med. 1963;14:215-242.
2. Dorschner RA, Pestonjamasp VK, Tamakuwala S, Ohtake T, Rudisill J, Nizet V, Agerberth B, Gudmunder GH, Gallo RL. Cutaneous injury induces release of cathelicidin antimicrobial peptides active against group A Strep. J. Invest. Dermatol. 2001;117:91-97.
3. Schauber J, Gallo RL. Antimicrobial peptides and the skin immune defense system. J. Allergy Clin. Immunol. 2008;122:261-266.
4. Rivas-Santiago B, Serrano CJ, Enciso-Moreno A. Susceptibility to infectious diseases based on antimicrobial peptide production. Infect. Immun. 2009;77:4690-4695.
5. Burtenshaw JM. The mechanisms of self disinfection of the human skin and its appendages. J. Hyg. 1942;42:184-209.
6. Weitkamp AW, Smiljanic AM, Rothman S. The free fatty acids of human hair fat. J. Am. Chem. Soc. 1947;69:1936-1939.
7. Thormar H, Hilmarsson H. The role of microbiocidal lipids in host defense against pathogens and their potential as therapeutic agents. Chem. Phys. Lipids 2007;150:1-11.
8. Drake DR, Brogden KA, Dawson DV,Wertz PW. Antimicrobial lipids at the skin surface. J. Lipid Res. 2008;49:4-11.
9. Wertz PW. Biochemistry of human stratum corneum lipids. In: Feingold K, Elias PM, (editors) Skin Barrier. New York: Marcel Dekker, Inc., 2006. pp. 33-42.
10. Elias PM. The skin barrier as an innate immune element. Semin. Immunopathol. 2007;29:3-14.
11. Wertz PW, Downing DT. Free sphingosine in porcine epidermis. Biochim. Biophys. Acta. 1989;1002:213-217.
12. WertzPW,DowningDT. Free sphingosine in human epidermis. J. Invest. Dermatol. 1990;94:159-161.
13. Wertz PW, Downing DT. Ceramidase activity in porcine epidermis. FEBS Lett. 1990;268:110-112.
14. Bibel DJ, Aly R, Shinefield HR. Antimicrobial activity of sphingosines. J. Invest. Dermatol. 1992;98:269-273.
15. Bibel DJ, Aly R, Shah S, Shinefield HR. Sphingosines: antimicrobial barriers of the skin. Acta. Derm. Venereol. 1993;73:407-411.
16. Payne CD, Ray TL, Downing DT. Cholesterol sulfate protects Candida albicans from inhibition by sphingosine in vitro. J. Invest. Dermatol. 1996;106:549-552.
17. Strum JC, Ghosh S, Bell RM. Lipid second messengers: a role in cell growth and cell cycle progression. Adv. Exp. Med. Biol. 1997;407:421-431.
18. Downing DT, Strauss JS. Synthesis and composition of surface lipids of human skin. J. Invest. Dermatol. 1974;62:228-244.
19. Wertz PW. Sebum secretion and acne. In: Rawlings AV, Webster T, (editors) Acne and Its Therapy. New York: Marcel Dekker, Inc., 2007. pp. 37-44.
20. Dale BA, Fredericks LP. Antimicrobial peptides in the oral environment: expression and function in health and disease. Curr. Issues Mol. Biol. 2005; 7: 119-134
21. Puy CL. The role of saliva in maintaining oral health and as an aid to diagnosis. Med. Oral Path. Oral Cir. Bucal. 2006;11:E449-E455.
22. Wertz PW, Squier CA. Biochemical basis of the permeability barrier in skin and oral mucosa. In: Rathbone MJ, (editor) Oral Mucosal Drug Delivery. Wilmington: AAI Inc., 1996. pp. 1-26.
23. Steen Law SL, Squier CA, Wertz PW. Free sphingosine in oral epithelium. Comp. Biochem. Physiol. 1994;110B:511-513.
24. Law S, Wertz PW, Swartzendruber DC, Squier CA. Regional variation in content, composition and organization of porcine epithelial barrier lipids revealed by thin-layer chromatography and transmission EM. Arch. Oral. Biol. 1995;40:1085-1091.
25. Squier CA, Wertz PW. Structure and function of the oral mucosa and implications for drug delivery. In: Rathbone MJ, (editor) Oral Mucosal Drug Delivery. Wilmington: AAI Inc., 1996. pp. 1-26.
26. Gorski M, Buchner A, Fundoianu-Dayan D, Cohewn C. Fordyce's granules in the oral mucosa of adult Israeli Jews. Comm. Dent. Oral. Epidemiol. 1986;14:231-232.
27. Batsakis JG, el-Naggar AK. Sebaceous lesions of salivary glands and oral cavity. Ann. Otol. Rhinol. Laryngol. 1990;99:416-418.
28. Daley T. Pathology of intraoral sebaceous glands. J. Oral. Pathol. Med. 1993;22:241-245. 29. Olivier JH. Fordyce granules on the prolabial and oral mucous membranes of a selected population. SADJ 2006;61:72-74.
29. Olivier JH. Fordyce granules on the prolabial and oral mucous membranes of a selected population. SADJ 2006;61:72-74.
30. Nordstrom KM, McGinley KJ, Lessin SR, Leyden JJ. Neutral lipid composition of Fordyce's granules. Brit. J. Dermatol. 1989;121:669-670.
31. James AT, Wheatley VR. Studies of sebum. 6. The determination of component fatty acids of human forearm sebum by gas-liquid chromatography. Biochem. J. 1956;63:269-273.
32. Haahti E. Major lipid constituents of human skin surface with special reference to gas chromatographic methods. Scand. J. Clin. Lab. Invest. 1961;13(Suppl. 59):1-108.
33. Kabara JJ, Swieczkowski DM, Conley AJ, Truant JP. Fatty acid derivatives as antimicrobial agents. Antimicrob. Agents Chemother. 1972;2:23-28.
34. Kabara JJ, Vrable R. Antimicrobial lipids: natural and synthetic fatty acids and monoglycerides. Lipids 1977;12:753-759.
35. Takigawa H, Nakagawa H, Kuzukawa M, Mori H, Imokawa G. Deficient production of hexadecenoic acid is associated in part with the vulnerability of atopic patients to colonization by Staphylococcus aureus. Dermatology 2005;211:240-248.
36. Stewart ME, Downing DT. Free sphingosines of human skin include 6-hydroxysphingosine and unusually long-chain dihydrosphingosines. J. Invest. Dermatol. 1995;105:613-618.
37. Imokawa G. Lipid abnormalities in atopic dermatitis. J. Am. Acad. Dermatol. 2001;45(Suppl. 1): S29-S32.
38. Abeck D, Mempel M. Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications. Brit. J. Dermatol. 1998;139:13-16.
39. Arikawa J, Ishibashi M, Kawashima M, Takagi Y, Ichikawa Y, Imokawa G. Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization with Staphylococcus aureus. J. Invest. Dermatol. 2002;119:433-439.